314 related articles for article (PubMed ID: 22753648)
21. Magnetic resonance imaging in ankylosing spondylitis.
Zochling J; Baraliakos X; Hermann KG; Braun J
Curr Opin Rheumatol; 2007 Jul; 19(4):346-52. PubMed ID: 17551364
[TBL] [Abstract][Full Text] [Related]
22. OMERACT magnetic resonance imaging initiative on structural and inflammatory lesions in ankylosing spondylitis--report of a special interest group at OMERACT 10 on sacroiliac joint and spine lesions.
Baraliakos X; van der Heijde D; Braun J; Landewé RB
J Rheumatol; 2011 Sep; 38(9):2051-4. PubMed ID: 21885516
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1).
Sieper J; van der Heijde D; Dougados M; Mease PJ; Maksymowych WP; Brown MA; Arora V; Pangan AL
Ann Rheum Dis; 2013 Jun; 72(6):815-22. PubMed ID: 22772328
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: a clinical and magnetic resonance imaging study.
Marzo-Ortega H; McGonagle D; O'Connor P; Emery P
Arthritis Rheum; 2001 Sep; 44(9):2112-7. PubMed ID: 11592375
[TBL] [Abstract][Full Text] [Related]
25. Development and Validation of MRI Sacroiliac Joint Scoring Methods for the Semiaxial Scan Plane Corresponding to the Berlin and SPARCC MRI Scoring Methods, and of a New Global MRI Sacroiliac Joint Method.
Hededal P; Østergaard M; Sørensen IJ; Loft AG; Hindrup JS; Thamsborg G; Asmussen K; Hendricks O; Nørregaard J; Møller JM; Jurik AG; Morsel L; Balding L; Pedersen SJ
J Rheumatol; 2018 Jan; 45(1):70-77. PubMed ID: 28966208
[TBL] [Abstract][Full Text] [Related]
26. Spondyloarthritis Research Consortium of Canada magnetic resonance imaging index for assessment of spinal inflammation in ankylosing spondylitis.
Maksymowych WP; Inman RD; Salonen D; Dhillon SS; Krishnananthan R; Stone M; Conner-Spady B; Palsat J; Lambert RG
Arthritis Rheum; 2005 Aug; 53(4):502-9. PubMed ID: 16082639
[TBL] [Abstract][Full Text] [Related]
27. Whole-body Magnetic Resonance Imaging in Axial Spondyloarthritis: Reduction of Sacroiliac, Spinal, and Entheseal Inflammation in a Placebo-controlled Trial of Adalimumab.
Krabbe S; Østergaard M; Eshed I; Sørensen IJ; Jensen B; Møller JM; Balding L; Madsen OR; Asmussen K; Eng G; Jørgensen NR; Pedersen SJ
J Rheumatol; 2018 May; 45(5):621-629. PubMed ID: 29449506
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of active inflammation, chronic structural damage, and response to treatment of sacroiliitis in axial spondyloarthritis using the Spondyloarthritis research consortium of Canada scoring system.
Zhang Y; Guo Z; Zhan Y; Qu J; Lei X
BMC Musculoskelet Disord; 2022 Jul; 23(1):654. PubMed ID: 35804360
[TBL] [Abstract][Full Text] [Related]
29. Brief Report: Six-Week Treatment of Axial Spondyloarthritis Patients With an Optimal Dose of Nonsteroidal Antiinflammatory Drugs: Early Response to Treatment in Signal Intensity on Magnetic Resonance Imaging of the Sacroiliac Joints.
Varkas G; Jans L; Cypers H; Van Praet L; Carron P; Elewaut D; Van den Bosch F
Arthritis Rheumatol; 2016 Mar; 68(3):672-8. PubMed ID: 26473982
[TBL] [Abstract][Full Text] [Related]
30. MR imaging of the spine and sacroiliac joints for spondyloarthritis: influence on clinical diagnostic confidence and patient management.
Carmona R; Harish S; Linda DD; Ioannidis G; Matsos M; Khalidi NA
Radiology; 2013 Oct; 269(1):208-15. PubMed ID: 23813394
[TBL] [Abstract][Full Text] [Related]
31. Modification of structural lesions on MRI of the sacroiliac joints by etanercept in the EMBARK trial: a 12-week randomised placebo-controlled trial in patients with non-radiographic axial spondyloarthritis.
Maksymowych WP; Wichuk S; Dougados M; Jones HE; Pedersen R; Szumski A; Marshall L; Bukowski JF; Lambert RG
Ann Rheum Dis; 2018 Jan; 77(1):78-84. PubMed ID: 28970212
[TBL] [Abstract][Full Text] [Related]
32. Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trial.
Song IH; Weiß A; Hermann KG; Haibel H; Althoff CE; Poddubnyy D; Listing J; Lange E; Freundlich B; Rudwaleit M; Sieper J
Ann Rheum Dis; 2013 Jun; 72(6):823-5. PubMed ID: 23172749
[TBL] [Abstract][Full Text] [Related]
33. Fat metaplasia and backfill are key intermediaries in the development of sacroiliac joint ankylosis in patients with ankylosing spondylitis.
Maksymowych WP; Wichuk S; Chiowchanwisawakit P; Lambert RG; Pedersen SJ
Arthritis Rheumatol; 2014 Nov; 66(11):2958-67. PubMed ID: 25047851
[TBL] [Abstract][Full Text] [Related]
34. The Ankylosing Spondylitis Disease Activity Score is a highly discriminatory measure of disease activity and efficacy following tumour necrosis factor-α inhibitor therapies in ankylosing spondylitis and undifferentiated spondyloarthropathies in China.
Xu M; Lin Z; Deng X; Li L; Wei Y; Liao Z; Li Q; Wei Q; Hu Z; Zhang Y; Lin Q; Huang J; Li T; Pan Y; Wu Y; Jin O; Yu B; Gu J
Rheumatology (Oxford); 2011 Aug; 50(8):1466-72. PubMed ID: 21441550
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of guselkumab in biologic-naïve patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trial.
Gladman DD; Mease PJ; Bird P; Soriano ER; Chakravarty SD; Shawi M; Xu S; Quinn ST; Gong C; Leibowitz E; Poddubnyy D; Tam LS; Helliwell PS; Kavanaugh A; Deodhar A; Østergaard M; Baraliakos X
Trials; 2022 Sep; 23(1):743. PubMed ID: 36064592
[TBL] [Abstract][Full Text] [Related]
36. Infliximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging study.
Marzo-Ortega H; McGonagle D; Jarrett S; Haugeberg G; Hensor E; O'connor P; Tan AL; Conaghan PG; Greenstein A; Emery P
Ann Rheum Dis; 2005 Nov; 64(11):1568-75. PubMed ID: 15829577
[TBL] [Abstract][Full Text] [Related]
37. Validation of the spondyloarthritis research consortium of Canada magnetic resonance imaging spinal inflammation index: is it necessary to score the entire spine?
Maksymowych WP; Dhillon SS; Park R; Salonen D; Inman RD; Lambert RG
Arthritis Rheum; 2007 Apr; 57(3):501-7. PubMed ID: 17394179
[TBL] [Abstract][Full Text] [Related]
38. The Discriminative Values of the Bath Ankylosing Spondylitis Disease Activity Index, Ankylosing Spondylitis Disease Activity Score, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Spondyloarthritis-Related Axial Arthritis.
Tsang HHL; Chung HY
J Clin Rheumatol; 2017 Aug; 23(5):267-272. PubMed ID: 28661926
[TBL] [Abstract][Full Text] [Related]
39. Impact of filgotinib on sacroiliac joint magnetic resonance imaging structural lesions at 12 weeks in patients with active ankylosing spondylitis (TORTUGA trial).
Maksymowych WP; Østergaard M; Landewé R; Barchuk W; Liu K; Tasset C; Gilles L; Hendrikx T; Besuyen R; Baraliakos X
Rheumatology (Oxford); 2022 May; 61(5):2063-2071. PubMed ID: 34352069
[TBL] [Abstract][Full Text] [Related]
40. Application of the OMERACT filter to scoring methods for magnetic resonance imaging of the sacroiliac joints and the spine. Recommendations for a research agenda at OMERACT 7.
van der Heijde DM; Landewé RB; Hermann KG; Jurik AG; Maksymowych WP; Rudwaleit M; O'Connor PJ; Braun J
J Rheumatol; 2005 Oct; 32(10):2042-7. PubMed ID: 16206367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
